Managers / Q2 2021 · view latest →
Mass General Brigham, Inc
CIK 0001678378 · 399 REVOLUTION DRIVE, SUITE 612, SOMERVILLE, MA, 02145 · 8572777268
Summary
Mass General Brigham, Inc reported $410M in U.S.-listed holdings across 9 positions for Q2 2021.
The portfolio is heavily concentrated: Ishares Core Sp 500 Etf alone accounts for 54.4% of reported value.
Compared with Q1 2021, the fund opened 7 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 90.0% · $369M
- Common Stock · 8.6% · $35M
- ADR · 1.1% · $4M
- Other · 0.3% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COINCOINBASE GLOBAL INC CLASS A | NEW | +128.9K | 128.9K | +$33M | $33M |
| PDDPINDUODUO INC ADR | NEW | +35.4K | 35.4K | +$4M | $4M |
| DOCUDOCUSIGN INC | NEW | +4.0K | 4.0K | +$1M | $1M |
| SNOWSNOWFLAKE INC CLASS A | NEW | +4.5K | 4.5K | +$1M | $1M |
| CRISPR THERAPEUTICS AG | NEW | +6.5K | 6.5K | +$1M | $1M |
| DELLDELL TECHNOLOGIES C | NEW | +4.0K | 4.0K | +$403,000 | $403,000 |
| JNCEEURJOUNCE THERAPEUTICS INC | NEW | +19.3K | 19.3K | +$131,000 | $131,000 |
| ACWIISHARES MSCI ACWI ETF | SOLD OUT | −847.1K | 0 | −$81M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES CORE SP 500 ETF | ETF | 54.41% | $223M | 518.8K |
| 2 | ISHARES CORE U.S. AGGREGATE ETF | ETF | 35.60% | $146M | 1.27M |
| 3 | COINCOINBASE GLOBAL INC CLASS Ahistory → | CL A | 7.97% | $33M | 128.9K |
| 4 | PDDPINDUODUO INC ADRhistory → | ADR | 1.10% | $4M | 35.4K |
| 5 | DOCUDOCUSIGN INC | COM | 0.27% | $1M | 4.0K |
| 6 | SNOWSNOWFLAKE INC CLASS A | CL A | 0.27% | $1M | 4.5K |
| 7 | CRISPR THERAPEUTICS AG | COM | 0.26% | $1M | 6.5K |
| 8 | DELLDELL TECHNOLOGIES C | CL C | 0.10% | $403,000 | 4.0K |
| 9 | JNCEEURJOUNCE THERAPEUTICS INC | COM | 0.03% | $131,000 | 19.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $469M | 6 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $810M | 7 | Jan 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $44M | 5 | Oct 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $21M | 4 | Jul 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $57M | 5 | Apr 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $28M | 2 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $11M | 2 | Oct 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 7 | Jul 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128,310 | 6 | Apr 5, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 5 | Jan 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $192M | 3 | Oct 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $214M | 3 | Jul 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $235M | 5 | Apr 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $282M | 7 | Jan 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $371M | 7 | Oct 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $410M | 9 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $639M | 3 | Apr 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $473M | 3 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $126M | 2 | Oct 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $290M | 3 | Jan 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $436M | 3 | Oct 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $153M | 1 | Jul 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $162M | 1 | Apr 18, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $144M | 1 | Jan 30, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.